| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_NFATC3_0003700 | Intron-Exon | chr16:68150936-68225678 | chr16:68117033-68191775 | 250 nt | 0.3280 |
| hsa_NFATC3_0004000 | Intron-Exon-Intron | chr16:68151432-68160513 | chr16:68117529-68126610 | 163 nt | 0.4479 |
| hsa_NFATC3_0004100 | Intron-Exon-Intron | chr16:68151606-68160513 | chr16:68117703-68126610 | 163 nt | 0.4479 |
| hsa_NFATC3_0005300 | Exon-Exon | chr16:68155890-68160463 | chr16:68121987-68126560 | 1248 nt | 0.4639 |
| hsa_NFATC3_0005000 | Intron-Exon-Intron | chr16:68155890-68165873 | chr16:68121987-68131970 | 250 nt | 0.3280 |
| hsa_NFATC3_0005100 | Intron-Exon-Intron | chr16:68155890-68165930 | chr16:68121987-68132027 | 250 nt | 0.3080 |
| hsa_NFATC3_0005400 | Intron-Exon-Intron | chr16:68155890-68172485 | chr16:68121987-68138582 | 1370 nt | 0.4642 |
| hsa_NFATC3_0005500 | Exon-Exon | chr16:68155890-68215433 | chr16:68121987-68181530 | 370 nt | 0.4135 |
| hsa_NFATC3_0005200 | Intron-Exon-Intron | chr16:68155890-68236357 | chr16:68121987-68202454 | 250 nt | 0.3360 |
| hsa_NFATC3_0005600 | Exon-Exon | chr16:68155890-68248335 | chr16:68121987-68214432 | 104 nt | 0.4712 |
A study in human peripheral whole blood samples selected the circNFATC3 for validation but eliminated it from the final age prediction model due to barely detectable expression (Ct >37) in RT-qPCR assays [Wang et al. DOI:10.3389/fgene.2022.1031806].